All Featured Insights

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation.

CMS releases results from the first round of Medicare Drug Price Negotiations, Steward finds a buyer for its physician group, and employers are using price transparency data in their suits against Aetna.

CVS to roll out co-located Oak Street Health clinics amid reduced profit outlook, CMS finalizes inpatient payment rule that includes new mandatory bundled payment model, and an appeals court gives providers another win in No Surprises Act litigation.

In this week’s graphic, we take stock of both the evolving usage and employer coverage of GLP-1 drugs, specifically for weight loss.

Community Health Systems plans to sell its three Pennsylvania hospitals, a bankruptcy judge allows Steward Health Care to close two Massachusetts hospitals, and CMS approves North Carolina’s medical debt relief program.

The House Oversight Committee criticizes PBM pricing tactics, Humana’s CenterWell plans to open primary care centers at Walmarts, and a federal judge upholds the FTC’s noncompete rule, diverging from a previous district court ruling.

Novant cancels its plan to acquire two North Carolina hospitals from CHS amid an FTC challenge, Amazon expands its RxPass generic drug subscription service to Medicare, and the DOJ accuses two executives at telehealth startup Done of an Adderall distribution scheme.

An FDA advisory committee recommends approval of Eli Lilly’s Alzheimer’s drug, the Biden administration proposes banning medical debt from credit reports, and Elevance becomes the second insurer to win a MA star ratings lawsuit.

Portland, OR-based health systems OHSU and Legacy sign a definitive merger agreement, Dollar General ends its mobile health clinic pilot, and a House subcommittee focuses on the need for 340B transparency.

Ozempic trial shows the drug slows kidney disease progression, a blood-based colorectal cancer test is endorsed for FDA approval, and nursing home trade groups sue over the new staffing mandate.

Telehealth company Hims & Hers unveils $199 weight-loss shots, CMS launches an emergency care complaint portal for patients, and the Senate Finance Committee signals interest in Medicare physician payment reforms.

Hospitals and health systems that participate in the federal 340B Drug Pricing Program are currently facing challenges on multiple fronts, including manufacturer restrictions and program audits, legal challenges, and constantly-evolving federal and state requirements for participation.